Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

✍ Scribed by Laura J. Esserman; Donald A. Berry; Maggie C. U. Cheang; Christina Yau; Charles M. Perou; Lisa Carey; Angela DeMichele; Joe W. Gray; Kathleen Conway-Dorsey; Marc E. Lenburg; Meredith B. Buxton; Sarah E. Davis; Laura J. van’t Veer; Clifford Hudis; Koei Chin; Denise Wolf; Helen Krontiras; Leslie Montgomery; Debu Tripathy; Constance Lehman; Minetta C. Liu; Olufunmilayo I. Olopade; Hope S. Rugo; John T. Carpenter; Chad Livasy; Lynn Dressler; David Chhieng; Baljit Singh; Carolyn Mies; Joseph Rabban; Yunni-Yi Chen; Dilip Giri; Alfred Au; Nola Hylton; The I-SPY 1 TRIAL Investigators

• Book ID: 113062359
• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 788 KB
• Volume: 132
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-011-1895-2